NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Stock Information | RedChip

NRX Pharmaceuticals Inc. (NASDAQ: NRXP)


$4.5100
+1.0000 ( +18.68% ) 3.5M

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Market Data


Open


$4.5100

Previous close


$3.5100

Volume


3.5M

Market cap


$49.46M

Day range


$3.5150 - $4.8210

52 week range


$1.1000 - $7.3330

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 18, 2024
3 Insider transactions 1 Nov 22, 2024
8-k 8K-related 17 Nov 20, 2024
8-k 8K-related 19 Nov 15, 2024
10-q Quarterly Reports 72 Nov 14, 2024
8-k 8K-related 17 Oct 31, 2024
8-k 8K-related 14 Oct 15, 2024
8-k 8K-related 16 Oct 11, 2024
def Proxies and info statements 4 Sep 05, 2024
pre Proxies and info statements 2 Aug 27, 2024

Latest News